A cancer diagnosis in India does not only produce hospital bills. It often stops a paycheck. Tata AIA Life Insurance took aim at that second problem on June 30, 2026, with two new products named Sampoorna Care – Cancer and Sampoorna Care – Cancer Fund.
Here’s what it means in plain terms. Ordinary health insurance pays for the hospital stay. It does not replace the salary of someone who cannot work for months. According to the International Agency for Research on Cancer, more than 1.57 million people in India are diagnosed with cancer every year, so a lot of households face that gap.
What the cancer plan pays
Cover goes up to ₹50 lakh. Policyholders pick how the money arrives: a lump sum, a regular monthly income, or an upfront payment followed by an income stream that can run for up to five years. Think of it like a salary that keeps landing in the account while the real one is on hold.
The plan also fixes the price: premium rates are guaranteed for 30 years. A Diagnostic Benefit helps cover early-stage testing, and an Overseas Treatment Booster tops up the payout by 10% of the sum assured when eligible treatment happens abroad soon after diagnosis.
The savings version
The second product, Cancer Fund, adds a health savings pot. Customers can put in one to three times their cancer protection premium and take money out tax-free for eligible healthcare costs. It bundles cover for accidental total and permanent disability, and buyers can opt to have premiums returned if nobody claims for cancer over the policy term. Hindu BusinessLine reported that the fund side combines two existing Tata AIA products, Health SIP and Health Buddy, while the cancer plan is a version of Sampoorna Care.
Why monthly income
The insurer says it asked buyers first. In its research, 48% of respondents preferred income payouts over a lump sum, and 76% wanted payments to run for several years. Hindu BusinessLine added that 47 per cent favoured monthly income, with 42 per cent choosing two years of payouts and 34 per cent choosing five.
Sujeet Kothare, Chief Business Officer for Proprietary Business, Propositions and Marketing at Tata AIA, said a diagnosis can disrupt family finances and long-term plans alike. The products, he said, are meant to cover income continuity, treatment expenses and savings together, reported Business Today.
The practical upshot for anyone shopping: the headline figure is the ₹50 lakh ceiling, but the income option is what separates this from a standard critical illness policy. Ask how the monthly payout is calculated before signing, since neither report gave premium prices or payout amounts.
For scale, Tata AIA reported ₹38,164 crore in total premium income for FY26, up 21 per cent on FY25. Its Individual Weighted New Business Premium came to ₹10,018 crore, which puts it in the top three private insurers on that measure.
Sources
- Sampoorna Care-Cancer: Tata AIA launches cancer cover with income replacement feature
- Tata AIA launches two cancer insurance plans with income replacement option
